Abshire Saylor Martha, Pavlovic Noelle V, DeGroot Lyndsay, Jajodia Anushka, Hladek Melissa deCardi, Perrin Nancy, Wolff Jennifer, Davidson Patricia M, Szanton Sarah
Johns Hopkins School of Nursing, Baltimore, MD, United States.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Contemp Clin Trials Commun. 2022 May 5;28:100917. doi: 10.1016/j.conctc.2022.100917. eCollection 2022 Aug.
For caregivers of people with heart failure, addressing a range of care recipient needs at home can potentially be burdensome, but caregivers may also gain meaning from caregiving. The Caregiver Support Program, a multicomponent strengths-based intervention, is designed to improve outcomes of heart failure caregivers.
This is a single-blind, two group, waitlist control trial. Eligible caregivers are 1) ≥ 18 years, 2) English speaking, 3) live with the person with heart failure or visit them at least 3 days per week to provide care, 4) provide support for at least 1 instrumental activity of daily living (IADL), 5) live within a 1 h driving radius of the Johns Hopkins Hospital, and 6) the care-recipient has been hospitalized within the last 6 months. Trial participants are randomized into the immediate intervention (n = 24) or waitlist control group (n = 24). Data collection is at baseline, 16 weeks, and 32 weeks.
The Caregiver Support program has the potential to increase quality of life and decrease fatigue and caregiver burden for caregivers of people with heart failure and multiple co-morbidities.
对于心力衰竭患者的照料者而言，在家中满足一系列照料对象的需求可能会带来负担，但照料者也可能从照料中获得意义。照料者支持计划是一种基于优势的多成分干预措施，旨在改善心力衰竭照料者的结局。
1）测试照料者支持计划在改善照料者生活质量（主要结局）以及从基线到16周的疲劳和负担（次要结局）方面的可行性并评估初始效应大小；2）测试疲劳和照料者负担是否与恢复力的客观指标（汗液炎症细胞因子（白细胞介素-6和白细胞介素-10）以及自我报告的恢复力）相关；3）评估干预前后心率变异性、白细胞介素-6和白细胞介素-10的变化。
这是一项单盲、两组、等待列表对照试验。符合条件的照料者需满足：1）年龄≥18岁；2）说英语；3）与心力衰竭患者同住或每周至少看望他们3天以提供照料；4）至少为一项日常生活工具性活动（IADL）提供支持；5）居住在约翰霍普金斯医院1小时车程范围内；6）照料对象在过去6个月内曾住院。试验参与者被随机分为立即干预组（n = 24）或等待列表对照组（n = 24）。数据收集时间为基线、16周和32周。
照料者支持计划有可能提高心力衰竭及多种合并症患者的照料者的生活质量，并减轻其疲劳和照料负担。
